Back to Search Start Over

Nonpeptidic, Monocharged, Cell Permeable Ligands for the p56lck SH2 Domain

Authors :
Proudfoot, J. R.
Betageri, R.
Cardozo, M.
Gilmore, T. A.
Glynn, S.
Hickey, E. R.
Jakes, S.
Kabcenell, A.
Kirrane, T. M.
Tibolla, A. K.
Lukas, S.
Patel, U. R.
Sharma, R.
Yazdanian, M.
Moss, N.
Beaulieu, P. L.
Cameron, D. R.
Ferland, J.-M.
Gauthier, J.
Gillard, J.
Gorys, V.
Poirier, M.
Rancourt, J.
Wernic, D.
Llinas-Brunet, M.
Source :
Journal of Medicinal Chemistry; July 2001, Vol. 44 Issue: 15 p2421-2431, 11p
Publication Year :
2001

Abstract

p56lck is a member of the src family of tyrosine kinases and plays a critical role in the signal transduction events that lead to T cell activation. Ligands for the p56lck SH2 domain have the potential to disrupt the interaction of p56lck with its substrates and derail the signaling cascade that leads to the production of cytokines such as interleukin-2. Starting from the quintuply charged (at physiological pH) phosphorylated tetrapeptide, AcpYEEI, we recently disclosed (J. Med. Chem. <BO>1999</BO>, 42, 722 and J. Med. Chem. <BO>1999</BO>, 42, 1757) the design of the modified dipeptide <BO>3</BO>, which carries just two charges at physiological pH. Here we present the elaboration of <BO>3 </BO>to the nonpeptidic, monocharged compound, <BO>9S</BO>. This molecule displays good binding affinity for the p56lck SH2 domain (K<INF>d</INF> 1 μM) and good cell permeation, and this combination of properties allowed us to demonstrate clear-cut inhibitory effects on a very early event in T cell activation, namely calcium mobilization.

Details

Language :
English
ISSN :
00222623 and 15204804
Volume :
44
Issue :
15
Database :
Supplemental Index
Journal :
Journal of Medicinal Chemistry
Publication Type :
Periodical
Accession number :
ejs1111738